Review: Amygdalin Loaded Nanoparticles in Cancer Treatment

In 2020, there were about 10 million fatalities and 19 million new instances of cancer, the leading cause of mortality worldwide. According to estimates, the number of cancer cases would rise to nearly 28 million by 2040 due to aging and population expansion[1].Amygdalin has been found to have a number of medical applications, including the treatment of asthma, enhancing immunological function, causing human kidney fibroblasts to undergo apoptosis, and preventing hyperglycemia. To precisely define this herb’s function in medical applications, further thorough in vitro and review research is needed.One well-known chemical compound that comes from a variety of fruits is amygdalin. Historically, the glycosides found in this plant have been used as an anticancer drug. An overview of amygdalin’s onco-immunity and other therapeutic medicinal uses was provided in this paper. [2]In addition to causing apoptosis, amygdalin has anticancer effects. According to experimental research, amygdalin in cancer cells activates caspase-3 and BAX and inhibits Bcl-2 and Poly (ADP-ribose) polymerase-1 (PARP-1), although there is little information on how these actions work.[3] Pharmaceutical nanocarriers that are currently in use, including liposomes, micelles, nanoemulsions, polymeric nanoparticles, and many more, exhibit a wide range of beneficial qualities, including the ability to treat a number of illnesses, including cancer, diabetes mellitus, metabolic disorders, and genetic disorders. Neurodegenerative illnesses, etc.According to other research, amygdalin has additional pharmacological effects, such as preventing pulmonary fibrosis, inhibiting renal interstitial fibrosis, suppressing and regulating the immune system, resistant to lung injury caused by hyperoxia, and having anti-inflammatory, antitumor, and anti-ulcer properties (Chang et al.[4].